San Francisco-based BPM (FY18 net revenue of $99.5 million) has hired Michael VanderKlugt and admitted him as a partner to lead the firm’s life science industry group.
The group serves diagnostic, therapeutic, medical device and digital health companies along the West Coast and beyond.
VanderKlugt comes to BPM after nearly 30 years at Deloitte, where he helped lead the life sciences team as it grew significantly. He will work with private companies in the growing industry, including adopting the new revenue recognition and lease accounting standards, applying for R&D credits, and supporting their finance and accounting functions through technical accounting, valuation and staffing needs.
“In other industries, audit isn’t life or death – but it could be for a life science company’s customers,” he says. “These companies have a passion for the success of their products and developing something that can provide help to disease-stricken individuals. It’s a more positive environment, and I find myself getting linked into their goals.”